Friedrich Amy Christine
Known title: President - Benefits & ProtectCIK: 0001707433
Associated companies
Transaction History
| PFG | ▲ Buy | Grant | 577 | $0 | 9/25/2026 | View on chart |
| PFG | ▲ Buy | Grant | 35,680 | $2.3M | 8/7/2026 | View on chart |
| PFG | ▼ Sell | Other | 35,680 | $4.1M | 8/7/2026 | View on chart |
| PFG | ▲ Buy | Grant | 599 | $0 | 6/26/2026 | View on chart |
| PFG | ▲ Buy | Grant | 707 | $0 | 3/27/2026 | View on chart |
| PFG | ▼ Sell | Tax Withholding | 3,801 | $363K | 2/27/2026 | View on chart |
| PFG | ▲ Buy | Grant | 9,959 | $0 | 2/23/2026 | View on chart |
| PFG | ▲ Buy | Grant | 9,653 | $0 | 2/23/2026 | View on chart |
| PFG | ▲ Buy | Grant | 548 | $0 | 12/19/2025 | View on chart |
| PFG | ▼ Sell | Gift | 1,524 | $0 | 12/4/2025 | View on chart |
| PFG | ▲ Buy | Grant | 576 | $0 | 9/26/2025 | View on chart |
| PFG | ▲ Buy | Grant | 579 | $0 | 6/27/2025 | View on chart |
| PFG | ▲ Buy | Grant | 537 | $0 | 3/28/2025 | View on chart |
| PFG | ▼ Sell | Tax Withholding | 3,885 | $346K | 2/28/2025 | View on chart |
| PFG | ▲ Buy | Grant | 8,673 | $0 | 2/24/2025 | View on chart |
| PFG | ▲ Buy | Grant | 11,490 | $0 | 2/24/2025 | View on chart |
| PFG | ▲ Buy | Grant | 419 | $0 | 12/18/2024 | View on chart |
| PFG | ▼ Sell | Gift | 5,780 | $0 | 11/19/2024 | View on chart |
| PFG | ▲ Buy | Grant | 358 | $0 | 9/27/2024 | View on chart |
| PFG | ▲ Buy | Grant | 11,165 | $417K | 9/16/2024 | View on chart |
| PFG | ▲ Buy | Grant | 11,010 | $691K | 9/16/2024 | View on chart |
| PFG | ▼ Sell | Other | 22,175 | $1.8M | 9/16/2024 | View on chart |
| PFG | ▲ Buy | Grant | 700 | $26K | 9/4/2024 | View on chart |
| PFG | ▲ Buy | Grant | 700 | $44K | 9/4/2024 | View on chart |
| PFG | ▼ Sell | Other | 1,400 | $115K | 9/4/2024 | View on chart |
| PFG | ▲ Buy | Grant | 379 | $0 | 6/28/2024 | View on chart |
| PFG | ▼ Sell | Gift | 6,273 | $0 | 5/22/2024 | View on chart |
| PFG | ▲ Buy | Grant | 337 | $0 | 3/28/2024 | View on chart |
| PFG | ▲ Buy | Grant | 9,031 | $0 | 2/26/2024 | View on chart |
| PFG | ▲ Buy | Grant | 8,302 | $0 | 2/26/2024 | View on chart |
| PFG | ▲ Buy | Grant | 210 | $0 | 12/20/2023 | View on chart |
| PFG | ▲ Buy | Grant | 221 | $0 | 9/29/2023 | View on chart |
| PFG | ▲ Buy | Grant | 203 | $0 | 6/30/2023 | View on chart |
| PFG | ▲ Buy | Grant | 207 | $0 | 3/31/2023 | View on chart |
| PFG | ▲ Buy | Grant | 7,921 | $0 | 2/27/2023 | View on chart |
| PFG | ▲ Buy | Grant | 7,385 | $0 | 2/27/2023 | View on chart |
| PFG | ▲ Buy | Grant | 6,290 | $323K | 1/4/2023 | View on chart |
| PFG | ▼ Sell | Other | 6,290 | $535K | 1/4/2023 | View on chart |
| PFG | ▲ Buy | Grant | 100 | $5K | 1/3/2023 | View on chart |
| PFG | ▼ Sell | Other | 100 | $9K | 1/3/2023 | View on chart |
| PFG | ▲ Buy | Grant | 63 | $0 | 12/19/2022 | View on chart |
| PFG | ▲ Buy | Grant | 73 | $0 | 9/30/2022 | View on chart |
| PFG | ▲ Buy | Grant | 76 | $0 | 6/24/2022 | View on chart |
| PFG | ▲ Buy | Grant | 264 | $0 | 3/25/2022 | View on chart |
| PFG | ▲ Buy | Grant | 8,116 | $0 | 2/28/2022 | View on chart |
| PFG | ▲ Buy | Grant | 5,832 | $0 | 2/28/2022 | View on chart |
| PFG | ▲ Buy | Grant | 146 | $0 | 12/21/2021 | View on chart |
| PFG | ▲ Buy | Grant | 150 | $0 | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Principal Financial Group (PFG) dividend focus and analyst target update
Recent coverage highlighted PFG’s dividend update, noting its 3.69% yield and suggesting the stock may be undervalued. At the same time, Wells Fargo kept an equal‑weight position but lowered its price target to $113, reflecting a more modest outlook. The company’s trailing P/E of 14.8 and support near $110.9 provide additional context for the discussion.
Principal Financial Group (PFG) dividend focus and analyst target update. Recent coverage highlighted PFG’s dividend update, noting its 3.69% yield and suggesting the stock may be undervalued. At the same time, Wells Fargo kept an equal‑weight position but lowered its price target to $113, reflecting a more modest outlook. The company’s trailing P/E of 14.8 and support near $110.9 provide additional context for the discussion.